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TET proteins oxidize 5-methylcytosine (5mC) to
5-hydroxymethylcytosine (5hmC), 5-formylcytosine
(5fC), and 5-carboxylcytosine (5caC). 5fC and 5caC
are excised by mammalian DNA glycosylase TDG,
implicating 5mC oxidation in DNA demethylation.
Here, we show that the genomic locations of 5fC
can be determined by coupling chemical reduction
with biotin tagging. Genome-wide mapping of 5fC in
mouse embryonic stem cells (mESCs) reveals that
5fC preferentially occurs at poised enhancers among
other gene regulatory elements. Application to Tdg
null mESCs further suggests that 5fC production co-
ordinates with p300 in remodeling epigenetic states
of enhancers. This process, which is not influenced
by 5hmC, appears to be associated with further
oxidation of 5hmCand commitment to demethylation
through 5fC. Finally, we resolved 5fC at base resolu-
tion by hydroxylamine-based protection from bisul-
fite-mediated deamination, thereby confirming sites
of 5fC accumulation. Our results reveal roles of active
5mC/5hmCoxidation and TDG-mediated demethyla-
tion in epigenetic tuning at regulatory elements.
INTRODUCTION
Epigenetic information encoded by 5-methylcytosine (5mC) has
a profound influence on mammalian development and human
disease (Klose and Bird, 2006). However, one of the most funda-
mental areas of interest, the active demethylation of 5mC in
mammalian cells, has only recently been unveiled (Bhutani
et al., 2011). 5mC was discovered to be further oxidized to
5-hydroxymethylcytosine (5hmC) by the TET family dioxyge-
nases in mammalian cells (Kriaucionis and Heintz, 2009; Tahi-
liani et al., 2009). TET family dioxygenases can further oxidize678 Cell 153, 678–691, April 25, 2013 ª2013 Elsevier Inc.5hmC to 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC)
in a stepwise manner (He et al., 2011; Ito et al., 2011; Pfaffe-
neder et al., 2011). The later oxidation products 5fC and 5caC
are recognized and excised by mammalian DNA glycosylase,
TDG, and subsequently converted to cytosine through base
excision repair (BER) (Corta´zar et al., 2011; Cortellino et al.,
2011; He et al., 2011; Maiti and Drohat, 2011; Zhang et al.,
2012), resulting in an active DNA demethylation pathway in
mammals.
Genomic profiling of 5hmC has revealed its association with
genes and gene regulatory elements, in particular, where
5hmC is most abundant and 5mC is depleted (Ficz et al., 2011;
Khare et al., 2012; Pastor et al., 2011; Song et al., 2011; Stadler
et al., 2011; Stroud et al., 2011; Szulwach et al., 2011; Williams
et al., 2011; Wu et al., 2011a; Xu et al., 2011; Yu et al., 2012).
Meanwhile, roles for 5hmC and TET-family proteins in normal
development (Dawlaty et al., 2011; Doege et al., 2012; Gu
et al., 2011; Ito et al., 2010; Koh et al., 2011; Williams et al.,
2011; Xu et al., 2011) and disease (Ko et al., 2010; Lian et al.,
2012; Moran-Crusio et al., 2011; Tan and Shi, 2012) continue
to emerge. As a result, it is becoming clear that although present
at low levels, oxidized forms of 5mC represent important
dynamic epigenetic states at functional genomic elements,
serving to modulate transcriptional programs. However, despite
these emerging paradigms, accurate methods for studying 5mC
oxidation beyond 5hmC are lacking.
To further understand how 5mC oxidation dynamics shape
patterns of DNA methylation, the genomic distribution of 5fC
and/or 5caC must be determined because these modifications
are ‘‘committed’’ to demethylation through BER. Unfortunately,
5fC and 5caC behave similarly to cytosine in bisulfite
sequencing-based methods (Booth et al., 2012; Yu et al.,
2012), and their low abundance in mammalian genomic DNA
(only ppm of total cytosines in mESC [Ito et al., 2011]) makes it
challenging to effectively apply antibody-based immunoprecipi-
tation, which typically works well with dense modifications
(Pastor et al., 2011). Here, we present two methods for
the distinction of 5fC in genomic DNA. We first introduced a
5-formylcytosine-selective chemical labeling (fC-Seal) approach
for genome-wide profiling of 5fC. Second, we developed a 5fC
chemically assisted bisulfite sequencing (fCAB-seq) method
for the base-resolution detection of 5fC. Application of these
methods to mESCs, as well as Tdg null mESCs, revealed the
genomic distribution and TDG-dependent regulation of 5fC.
Genome-wide 5fC profiling further revealed distinct properties
of 5mC/5hmC oxidation at various gene regulatory elements,
beyond that afforded by 5hmC profiling alone. Our results
show that 5fC is enriched at poised and active enhancers but
exhibits a preference to poised enhancers, suggesting a role
for 5mC/5hmC oxidation to 5fC in the epigenetic priming of en-
hancers. Finally, in support of this role, we find that accumulation
of 5fC in the absence of TDG correlates with increased binding of
the transcriptional coactivator p300 at poised enhancers. There-
fore, active 5mC/5hmC oxidation and TDG-coupled BER serve
to dynamically regulate epigenetic states at functional regulatory
elements in mammalian genomes.
RESULTS
fC-Seal for Selective Chemical Labeling and Capture
of 5fC
We and others previously have developed selective chemical
labeling of 5hmC with biotin for genome-wide profiling that is
highly sensitive and specific without density bias (Matarese
et al., 2011; Pastor et al., 2011; Song et al., 2011). In duplex
DNA, 5fC can be selectively reduced by sodium borohydride
(NaBH4) to 5hmC (Figure 1A) (Dai andHe, 2011), which prompted
us to develop fC-Seal. In this strategy, 5hmC is first blocked with
unmodified glucose using b-glucosyltransferase (bGT). We then
reduce 5fC to 5hmC using NaBH4 and label the newly generated
5hmC (derived from 5fC) with an azide-modified glucose. The
challenge of selectively capturing and profiling 5fC is therefore
solved by employing the 5hmC-selective chemical labeling
method (hMe-Seal) that we developed previously (Figure 1B).
We used a 9-mer duplex model DNA to confirm that NaBH4-
based reduction of 5fC to 5hmC can be carried out in aqueous
solution and that 5fC can be labeled with azide-modified glucose
only after reduction using mass spectrometry (MS) (Figure 1C).
The glucosylation protection of 5hmC is quantitative (Yu et al.,
2012) and protected 5hmC, as well as 5caC and 5mC, cannot
be reduced by NaBH4 under our reaction conditions (Figure S1
available online). We further confirmed the specificity of the
NaBH4-based 5fC reduction on synthetic DNA by HPLC (Fig-
ure S1D). In addition, we performed pull-down assays from
genomic DNA spiked with a pool of 2 kb amplicons bearing C,
5mC, 5hmC, 5fC, or 5caC. Quantitative PCR analyses confirmed
that fC-Seal only enriched 5fC-containing DNA, and that enrich-
ment is NaBH4 dependent (Figure 1D). In comparison to a hy-
droxylamine-based method for the labeling of 5fC (Raiber
et al., 2012), our method significantly reduced the capture of
nonspecific DNA (Table S1).
Parallel Genome-wide Profiling of 5fC and 5hmC
in Wild-Type mESCs
Using hMe-Seal and fC-Seal, we first performed parallel 5fC and
5hmC profiling in wild-type mESCs (Tdgfl/fl) (Figure 2). Whensequencing to comparable depths, biological replicates of 5fC
and 5hmC profiling were highly reproducible (Figure S2A, Tables
S2 and S3). We defined high-confidence 5fC- and 5hmC-
containing regions in Tdgfl/flmESCs (see Extended Experimental
Procedures) using a Poisson-based method (Zhang et al., 2008)
(Table S4, p% 13 105, FDR% 1%) (Figure 2A). Sequencing of
glucose-blocked, non-NaBH4-treated DNA subjected to biotin
labeling and capture confirmed complete blocking of 5hmC (Fig-
ure 2A, S2B, and Table S4). Each set of regions was first
compared to base-resolution maps of 5hmC and 5mC+5hmC
in mESCs (Stadler et al., 2011; Yu et al., 2012). On average,
5mC+5hmC abundance is 6.4% lower at regions marked with
5fC compared to 5hmC-enriched regions (Figure 2B), whereas
5hmC abundance is slightly higher (0.8%) at 5fC-marked regions
(Figure 2C), suggesting a localized increase in 5mC oxidation at
5fC-marked loci. As 5fC-marked loci have comparatively higher
5hmC levels, likely due to an increase in localized Tet-mediated
5mC oxidation, we subsequently separated 5fC+5hmC regions
(formyl- and hydroxymethyl-marked regions [fhMRs]) and
regions marked only by 5hmC but not 5fC (5-hydroxymethylated
only regions [hMRs]). Within hMRs, there are 2.003more 5hmC
bases than expected by chance (Figure 2D, Z score = 385) and
92.0% have at least one 5hmC base (Figure S2C). Yet, at fhMRs
there are 2.593 more 5hmC bases than expected (Figure 2D,
Z score = 413) and 89.2% of the 5fC-enriched regions contain
at least one 5hmC base (Figure S2C), consistent with the obser-
vation that 5fC-marked regions contain an overall increase in
oxidized 5mC in comparison to 5hmC-marked regions. These
data demonstrate a relative decrease of 5mCoccurring concom-
itant with an increased frequency and abundance of 5hmC at
fhMRs compared to hMRs, indicating further refinement of
genomic elements through mapping 5fC.
fhMRs Further Refine Diverse Gene Regulatory
Elements
Previous efforts have localized 5hmC to TSSs, gene bodies, and
enhancers, as well as CTCF-binding sites, with the overall abun-
dance highest at promoter distal regulatory elements (Ficz et al.,
2011; Jin et al., 2011; Pastor et al., 2011; Song et al., 2011;
Stroud et al., 2011; Szulwach et al., 2011; Williams et al., 2011;
Wu et al., 2011a; Xu et al., 2011; Yu et al., 2012), which may indi-
cate distinct mechanisms for the regulation of 5mC oxidation at
diverse gene regulatory elements. We therefore associated
fhMRs and hMRs with genomic and epigenomic annotations,
comparing them to equal numbers of equal length fragments
randomized throughout the genome (Figure 2E). Notably, both
fhMRs and hMRs are enriched at Tet1-binding sites (Williams
et al., 2011; Wu et al., 2011b) (Figure 2E, observed to expected,
o/e = 11.75, and o/e = 4.07) as well as at Tet2-binding sites (Fig-
ure 2E, o/e = 6.36 and o/e = 2.83) (Chen et al., 2013), correspond-
ing to a 2.89- and 2.25-fold preference for fhMRs versus hMRs
(fhMR:hMR), respectively (Figure S2D). fhMRs are enriched in-
tragenically, particularly within exons, (Figure 2E and S2D,
o/e = 4.58, fhMR:hMR = 1.61), strongly enriched at enhancers
(Figure 2E and S2D o/e = 8.71, fhMR:hMR = 1.87), but are
depleted at intergenic regions (Figure 2E and S2D, o/e = 0.60,
fhMR:hMR = 0.89). Enrichment of fhMRs is further increased at
enhancers predicted as linked to promoters on the basis ofCell 153, 678–691, April 25, 2013 ª2013 Elsevier Inc. 679
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Figure 1. Selective Labeling of 5fC in Genomic DNA
(A) 5fC is selectively reduced to 5hmC.
(B) General procedure for fC-Seal. Endogenous 5hmC is blocked by a regular glucose through bGT-catalyzed glucosylation. 5fC is then reduced to
5hmC by NaBH4. The newly generated 5hmC from 5fC can be specifically enriched for sequencing using the 5hmC-selective chemical labeling method
(hMe-Seal).
(C) MALDI-TOF characterization of 5fC-containing 9-mer duplex DNA in bGT-catalyzed blocking with unmodified glucose, NaBH4-based reduction, and
bGT-catalyzed azide-glucose labeling. Calculated MS shown in black, observed MS shown in red.
(D) Enrichment tests of a single pool of spike-in amplicons containing C, 5mC, 5hmC, 5fC, or 5caC, separately, using hMe-Seal and fC-Seal with NaBH4, or a
control with methanol only. Values shown are fold-enrichment over input, normalized to 5mC-modified DNA (n = 3, mean ± SEM). See also Figure S1 and
Table S1.
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correlated chromatin state and RNAPII occupancy (Figure S2E,
o/e = 9.61, fhMR:hMR = 1.92) (Shen et al., 2012), suggesting that
promoter-linked enhancers may be more prone to 5mC/5hmC
oxidation.
We also found depletion of fhMRs at repeat element classes
including LINEs, LTRs, and DNA repeats (Figure S2F). Although
repeat elements are generally depleted of fhMRs, among these
repeat classes, fhMRs most frequently associate with SINEs
(Figures S2F and S2G). fhMRs occur more frequently than
expected at p300-binding sites (o/e = 4.23, fhMR:hMR = 1.44),
DNaseI hypersensitive sites (DHSs) (o/e = 5.40, fhMR:hMR =
1.58), and are further enriched at H3K4me1-positive DHSs
(o/e = 8.03, fhMR:hMR = 1.90), thus supporting the strong asso-
ciation of 5mC oxidation with enhancers (Figure 2E and
S2D). Furthermore, fhMRs are enriched at poised enhancers
(H3K4me1[+] H3K27ac[], o/e = 9.57, fhMR:hMR= 1.99) in com-
parison to active enhancers (H3K4me1[+] H3K27ac[+],
o/e = 4.71, fhMR:hMR = 1.17) (Creyghton et al., 2010; Rada-
Iglesias et al., 2011; Zentner et al., 2011), implicating 5mC oxida-
tion to 5fC in the preferential marking of these elements
(Figure 2E and S2D). CTCF-bound regions are also associated
with fhMRs (o/e = 2.67), although at a reduced frequency relative
to hMRs (fhMR:hMR = 0.87) (Figure 2E and S2D). In contrast to
Tet1, Tet2, p300, and CTCF sites, measurement of normalized
5fC read densities at 18 additional sets of diverse transcription
factors showed that 5fC is not strongly enriched at these
elements (Figure S2H). As p300 and CTCF interact with various
transcription factors, this observation may support a role for
5mC oxidation and TDG-coupled removal of 5fC at regulatory
elements ‘‘organized’’ by these factors. These results suggest
that some regulatory elements, such as enhancers, may be
more prone to 5mC/5hmC oxidation, whereas others, such as
CTCF-bound loci, may contain more stable 5hmC.
5fC Is Preferentially Enriched at Poised Enhancers
and LMRs
Overall, we found that 21.1% of fhMRs are associated with an
enhancer, significantly more than observed for hMRs (14.4%)
(Figure 2E, p % 2.2 3 1016, Fisher’s exact). Among enhancer
subtypes, we also observed a significant increase in the
frequency of fhMRs at poised (H3K4me1[+] H3K27ac[],
o/e = 9.57) versus active (H3K4me1[+] H3K27ac[+], o/e = 4.71)
enhancers (Figure 2E, p % 2.2 3 1016, Fisher’s exact). The
association between fhMRs and poised enhancers is further
strengthened with those predicted as functionally linked to
promoters, approaching that observed for Tet1 (Figure S2E,
o/e = 10.95, fhMR:hMR = 2.14) (Shen et al., 2012). Comparison
between fhMRs and hMRs also revealed that fhMRs occur
more frequently than hMRs at poised versus active enhancers
(Figure 2E, p % 2.2 3 1016, Fisher’s Exact). Consistent with
the strong link between fhMRs and enhancers, particularly
poised enhancers, quantification of H3K4me1- and H3K27ac-
normalized ChIP-seq read densities at fhMRs and hMRs demon-
strated a clear distinction in H3K4me1 signal, but not H3K27ac
(Figure 2F).
We next measured methylation levels, as defined by con-
ventional whole-genome bisulfite sequencing (WGBS) and Tet-
assisted bisulfite sequencing (TAB-seq) of 5hmC in normalmESCs (Stadler et al., 2011; Yu et al., 2012) at enhancer associ-
ated fhMRs and hMRs. At poised enhancers predicted as linked
to promoters (poised enhancer-promoter [EP]), there is a higher
average abundance of 5hmC within fhMRs compared to hMRs,
consistent with the overall increase in 5mC oxidation at fhMRs
(Figure 2G). Conversely, there is a depletion of 5mC only at
fhMRs, but not hMRs. On the other hand, active enhancers
(H3K4me1[+] H3K27ac[+]) display a 20% reduction in 5mC
from an average 74% down to 53% (Figure 2G). Active
enhancers also show a lack of 5hmC compared to poised
enhancers at fhMRs or hMRs (Figure 2G). These results indicate
that within regions defined as poised EPs on the basis of histone
modifications, the presence of 5fC and 5hmC correlates with a
reduced methylation state relative to the presence of 5hmC
alone. This distinction among poised EPs may reflect the link
between TDG-mediated removal of 5fC and dynamic active
demethylation at this particular subset of enhancers.
Measurements of 5fC and 5hmC signals at segments of the
mESC methylome defined on the basis of DNA methylation
(5mC+5hmC) using conventional WGBS (Stadler et al., 2011)
(un-, low-, and fully methylated regions; UMRs, LMRs, and
FMRs, respectively) revealed that 5fC and 5hmC strongly accu-
mulate specifically at the LMR fraction of the mouse methylome
(Figures S2I and S2J). Notably, LMRs, harboring reduced
5mC+5hmC levels (30% abundance), are frequently present
at promoter distal regulatory elements and contain binding
sites/motifs for diverse transcription factors (Stadler et al.,
2011). It is also interesting to note the small amount of 5fC
captured at the previously assigned UMRs (Stadler et al.,
2011); 5fC behaves as C under conventional bisulfite conditions.
The presence of 5fC suggests that these sites could represent a
subclass of UMRs that are undergoing active 5mC/5hmC oxida-
tion in the presence of Tet1 and/or Tet2.
Together, the results support a model of relatively strong DNA
demethylation at promoter distal regulatory regions and selected
transcription factor binding sites, as has been previously pro-
posed (Stadler et al., 2011; Yu et al., 2012). The particularly
strong link between H3K4me1 and fhMRs in comparison to
hMRs indicates that further oxidation of 5hmC toward
demethylation occurs at the subsets of 5hmC-containing regions
associated with enhancers.
TDG Affects 5fC Deposition in mESCs
We next compared the genome-wide distributions of 5fC and
5hmC between wild-type and Tdg/ mESCs. Detailed pluripo-
tency and self-renewal characterization on the Tdgfl/fl and
Tdg/mESCs found no evidence for altered self-renewal or plu-
ripotency between floxed and Tdg/ cell lines (Figure S3A–S3E)
(Corta´zar et al., 2011). LC-MS/MS quantification of 5fC and
5hmC showed that Tdg knockout leads to 2-fold increase of
5fC in genomic DNAwith no significant change of the 5hmC level
(Figure 3A and 3B).
On a genomic scale, sequence reads derived from the DNA
containing 5fC also indicate accumulation of 5fC in Tdg/
mESCs (Figure 3C, r2 = 0.80) with little difference in the 5hmC
pattern (Figure 3D, r2 = 0.93), consistent with the fact that TDG
lacks 5hmC glycosylase activity (Cortellino et al., 2011; Maiti
and Drohat, 2011). As 5fC is derived from the iterative oxidationCell 153, 678–691, April 25, 2013 ª2013 Elsevier Inc. 681
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of 5mC/5hmC, we found that R89% of 5fC-marked regions
could be explained by 5hmC enrichment regardless of genotype
(Figures 3E, 3F, and S3F and Table S4). However, although only
32.6% of 5hmC-enriched regions contain 5fC in Tdgfl/fl mESCs,
in Tdg/ mESCs, the fraction of 5hmC-enriched regions also
harboring 5fC increases significantly to 54.9% as expected
based on the elevated level of 5fC (Figures 3E and 3G and Table
S4, p < 1. 3 104).
The absence of TDG in mESCs causes alterations in DNA
methylation states upon differentiation and during embryonic
development (Corta´zar et al., 2011; Cortellino et al., 2011). We
therefore measured 5fC and 5hmC levels in Tdgfl/fl and Tdg/
mESCs differentiated to embryoid bodies (mEBs). In mEBs the
5hmC level decreased by 50% (Figure S4A), whereas the 5fC
level was further decreased to 15% of that in mESCs (Fig-
ure S4B). The depletion of 5hmC and 5fC in mEBs agrees with
a previous report (Pfaffeneder et al., 2011) and the observation
that Tet1/Tet2 expression is reduced upon differentiation (Koh
et al., 2011). Because the 5fC levels in Tdgfl/fl and Tdg/
mEBs are similar, we performed hMe-Seal and fC-Seal in Tdgfl/fl
mEBs. In accordancewith the quantification data, there is a clear
reduction in the total number of 5fC-marked regions in mEBs
(Figure S4C) as well as in mEB-normalized 5fC read densities
at regions marked by 5fC in mESCs (Figure S4D).
TDG-Dependent 5fC at Selective Regulatory Elements
of mESCs
Assessment of normalized 5fC signals also revealed a clear
accumulation of 5fC at Tet1-bound loci in Tdg/ mESCs, as
well as at other genomic elements normally enriched for 5fC
but no difference between genotypes in immediately adjacent
regions (Figures 4A–4E). Comparison to 18 additional sets of
transcription-factor-binding sites also indicated that TDG-
dependent regulation occurs preferentially at Tet1-, Tet2-,
p300-, and CTCF-binding sites, but not uniformly across all
types of binding sites (Figure 4E). Furthermore, among 5fC sites
that are specifically found in Tdg/mESCs, we observed more
frequent associations with DHS and p300- and CTCF-bound loci
as well as TSSs as compared to 5fC sites in Tdgfl/fl mESCs (Fig-
ure S4E). At UMRs, LMRs, and FMRs, we found preferential
acquisition of 5fC within LMRs relative to UMRs and FMRs (Fig-
ure 4F). Gains of 5fC at both LMRs and UMRs occur without
concomitant decreases in 5hmC (Figure 4F).Figure 2. Annotation and Comparison of 5hmC- and 5fC-Containing R
(A) Genome browser view of the En2 locus in 5fC- and 5hmC-specific profiling, al
Below each track are regions defined as marked with each respective mark. The g
et al., 2012).
(B) Quantification of %5mC+5hmC at 5fC- and 5hmC-marked regions in Tdgfl/fl
(C) Quantification of %5hmC at 5fC- and 5hmC-marked regions in Tdgfl/fl mESC
(D) The relative enrichment of single-base 5hmC calls from (Yu et al., 2012) within f
defined by conventional bisulfite sequencing (Stadler et al., 2011) (ten iteration
covered by each set of enriched/random regions in megabases (Mb) and divided
(E) Percentage of fhMRs and hMRs overlapping a given genomic/epigenomic an
equal number and length (mean ± SD). Vertical values above bars indicate the o
annotations are listed in the left panel and epigenomic annotations are listed on
(F) H3K4me1 and H3K27ac normalized read densities at fhMRs (red) and hMRs
(G)%5hmC (top panel) and%5mC (bottom panel) at fhMRs (red) and hMRs (blue)
(black). See also Figure S2 and Tables S2, S3, and S4.A previous report suggested that 5fC is present and regulated
by TDG at the TSS-associated CpG islands of transcribed
genes, which are also depleted of 5hmC (Raiber et al., 2012).
Instead, we found that in Tdgfl/fl mESCs, 5fC is most enriched
at the TSSs of genes with low expression (Figure 4G), where
5hmC is highest, consistent with the fact that 5fC is derived
from 5hmC. Through further examination of TSSs ranked by
expression level (RNA-seq RPKM) in Tdg/ mESCs, we found
that the absence of TDG leads to accumulation of 5fC at the
promoter regions of genes with low to intermediate expression,
whereas 5hmC remained unchanged (Figures 4G and 4H and
Table S5). This observation indicates that TDG-mediated regula-
tion of 5fC occurs at ‘‘poised’’ genes in mESCs, similar to that
described for 5hmC (Pastor et al., 2011; Williams et al., 2011;
Wu et al., 2011b). Although these various gene regulatory
regions are each marked with 5hmC under normal conditions,
the increased frequency of 5fC without a change of 5hmC in
Tdg/ mESCs indicate that these regions are more likely to be
undergoing TDG-dependent removal of 5fC in a demethylation
process that couples TET oxidation with TDG-based BER.
TDG-Dependent Regulation of 5fC Correlates with p300
Binding
We took advantage of the altered 5fC content in Tdg/ mESCs
to further explore the impact of 5fC accumulation at sites of tran-
scription factor binding. To do so, we focused on the transcrip-
tional coactivator p300 because TDG and p300/CBP are known
to interact, providing a link between DNA demethylation and
p300 localization (Cortellino et al., 2011; Tini et al., 2002). By
mapping p300 genome-wide in Tdgfl/fl and Tdg/ mESCs, we
found that the vast majority of high-confidence p300 sites in
Tdgfl/fl mESCs (79.2%) remained in Tdg/ mESCs (Figures
5A, S5A, and S5B, and Table S4), indicating that the loss of
TDG does not widely disrupt p300 localization to chromatin.
However, examination of p300 binding in Tdg/ mESCs identi-
fied a 31.2% increase in the total number of high-confidence
p300-binding sites (Figure 5A and Table S4) with 43% marked
by 5fC (Figure S5C), significantly more than that observed in
Tdgfl/fl mESCs (12.9%, p < 2.2 3 1016, Fisher’s exact). In the
absence of TDG, a total of 16,503 unique p300 sites were
acquired, as opposed to only 6,683 sites unique to Tdgfl/fl
mESCs (Figures 5A and 5B), and an increased proportion of
these p300 sites were also marked with 5fC in comparisonegions in Wild-Type mESCs
ong with the input as well as the glucose-blocked, non-NaBH4-treated control.
old track at the bottom corresponds to known poised enhancers at En2 (Shen
mESCs.
s.
hMRs and hMRs Tdgfl/flmESCs.mC random are randomly sampled 5mCbases
s, mean ± SD). 5hmC base call counts are normalized in the genomic space
by 103. Values above bars indicate the o/e ratios.
notation compared to the average percent overlap of ten randomized sets of
/e ratios with significant enrichment (p < 1 3 1015, Fisher’s exact). Genomic
the right.
(blue).
associated with poised enhancer-promoters (poised EP) and active enhancers
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Figure 3. Comparison of 5fC and 5hmC Sig-
nals in Tdgfl/fl and Tdg/ mESCs
(A and B) Mass spectrometry quantification of the
genomic content of 5fC (A) and 5hmC (B) relative to
cytosine in Tdgfl/fl and Tdg/ mESCs in fC-Seal.
Error bars indicate SEM. for n = 4 experiments. The
red dotted lines indicate the detection limits under
the assay conditions.
(C and D) Scatter plot of input-normalized 5fC (C)
and 5hmC (D) read counts (reads/million) in 10 kb
bins genome-wide in Tdgfl/fl and Tdg/ mESCs.
Read counts per 10 kb bin are normalized to the
total number of reads in millions and similarly
normalized values from input control genomic DNA
subtracted. R2 values are denoted in the upper left-
hand corner and the black diagonal is provided for
reference.
(E) Venn diagram of the number of 5fC-marked
regions (red) overlapping 5hmC-enriched regions
(blue) in Tdgfl/fl (top) and Tdg/ (bottom) mESCs.
(F and G) The percentage of the genomic regions
with 5fC also marked with 5hmC (F) and the
percentage of 5hmC-enriched regions also con-
taining 5fC (G). See also Figure S3.to Tdgfl/fl mESCs (Figures S5D and S5E). Neither p300 nor CBP
displayed significantly altered expression (p300: Tdgfl/fl =
25.887, Tdg/ = 27.431, RPKM, p value = 0.22; CBP: Tdgfl/fl =
7.274, Tdg/ = 7.571, RPKM, p value = 0.41). Subsequent
quantification of normalized 5fC read densities at p300 sites
acquired in Tdg/ demonstrated a strong gain in 5fC without
changes in 5hmC (Figure 5C). Yet, at sites consistently bound
by p300 in each genotype, and at which 5fC was not detected,
we did not observe as significant an increase in p300 binding,684 Cell 153, 678–691, April 25, 2013 ª2013 Elsevier Inc.nor did we observe accumulation of 5fC
in the absence of TDG (Figures S5F and
S5G). These common p300 sites exhibit
significantly stronger p300 binding (Fig-
ure 5D, p < 1016 Welch’s two-tailed t
test) and reduced levels of 5mC+5hmC
as compared to sites of Tdg/-specific
p300 acquisition (Figure 5E).
The acquisition of a relatively large
number of p300-binding sites in the
absence of TDG, which concomitantly
accumulate 5fC, suggests that the active
oxidation of 5mC/5hmC to 5fC may serve
as an initial step to counteract 5mC and to
facilitate p300 binding; however, we
cannot rule out the possibility that a
more open chromatin state correlates
with increased p300 binding and 5mC/
5hmC oxidation. Further oxidation and
removal of 5fC could facilitate p300
binding on chromatin by generating or
maintaining a reduced methylation state,
as indicated by both the decreased
5mC+5hmC signal at sites with stronger
p300 binding (Figure 5E) and the overallnegative correlation between p300 binding strength and 5fC/
5hmC levels (Figure S5H). Distinct chromatin states could exist
at regions that acquire p300 binding in Tdg/ mESCs when
compared to p300 sites lacking 5fC that are common between
both genotypes. Indeed, Tdg/ acquired p300 sites occur pref-
erentially at regions normally marked by histone modifications
defining poised enhancers (H3K4me1[+]H3K27ac[]) in com-
parison to 5fC-negative p300 sites consistently identified in
each genotype, which occur preferentially at active enhancers
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Figure 4. TDG-Dependent 5fC Regulation at Defined Gene Regulatory Elements
(A–D) Log2 ratios of 5fC- and 5hmC-normalized read densities (reads/million/base, Tdg/: Tdgfl/fl) at genomic elements enriched for 5fC in Tdgfl/fl and Tdg/
mESCs. (A) Tet1, (B) CTCF, (C) p300, and (D) H3K4me1+DHS. Each region of interest, denoted as the central portion of the x axis, was divided into bins of ten
equal portions and reads were intersected to ten bins within, upstream, and downstream of each region.
(E) Heatmap representation of the Log2 ratios of 5fC-read densities (reads/million/base, Tdg/: Tdgfl/fl) at 22 distinct sets of transcription factor (TF)-binding sites.
(F) Log2 ratio of the normalized 5fC and 5hmC read densities (reads/million/base, Tdg/: Tdgfl/fl) at FMRs, LMRs, and UMRs. Normalized read densities are
plotted ±3 kb from the center of each segment as log2 fold-enrichment over input normalized read densities.
(G) Heatmap representations of 5fC-normalized read densities (reads/million/base) at RefSeq TSSs/TESs (±5 kb). 5fC signals at genes that are ranked byRPKM in
descending order. Heatmap scales correspond to normalized read densities.
(H) Heatmap representations of 5hmC-normalized read densities (reads/million/base) at RefSeq TSSs/TESs (±5 kb). 5hmC signals at genes that ranked by RPKM
in descending order. Heatmap scales correspond to normalized read densities. See also Figure S4 and Table S5.(H3K4me1[+]H3K27ac[+]) (Figure 5F, p < 2.2 3 1016, Fisher’s
exact). These effects are apparent at Fgf4 (Figure 5G), a key
regulator of ES cell differentiation (Wilder et al., 1997). Our find-ings suggest that the active oxidation of 5mC/5hmC to 5fC
could serve as an epigenetic priming mechanism at poised
enhancers.Cell 153, 678–691, April 25, 2013 ª2013 Elsevier Inc. 685
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Figure 5. TDG-Dependent p300 Binding in Tdgfl/fl and Tdg/ mESCs
(A) Venn diagram summarizing the total number of p300 ChIP-seq peaks identified in Tdgfl/fl (32,160) and Tdg/ mESCs (42,202), the number of Tdg/ p300
sites overlapping with Tdgfl/fl sites (25,699), and the number of p300 sites unique to Tdgfl/fl (6,683) and Tdg/ mESCs (16,503).
(B) p300 ChIP-seq signals (reads/million/base) at the Tdg/-specific p300-binding sites (16,503).
(legend continued on next page)
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Single-Base-Resolution Detection of 5fC
We next sought to develop an independent method for detecting
5fC at base resolution to further confirm the presence and accu-
mulation of 5fC at defined sites. 5fC can be converted to uracil in
bisulfite sequencing (Booth et al., 2012). If a specific chemical
treatment prevents 5fC from bisulfite-mediated deamination,
we can determine 5fC at base resolution through a chemically
assisted bisulfite sequencing method (fCAB-seq). Both hydrox-
ylamine-protected 5fC (Figures 6A, S6A, and S6B) and reduction
of 5fC to 5hmC could protect 5fC from bisulfite-mediated deam-
ination; we found that the O-ethylhydroxylamine (EtONH2)-
based protection of 5fC against bisulfite-mediated deamination
is more effective (Figure S6B). Through comparison of EtONH2-
treated bisulfite sequencing and traditional bisulfite sequencing
of the same sample, we can determine the genomic locations
of 5fC at single-base level (Figure 6A). Using a 76-mer DNA
model, we determined a working curve for 5fC conversion in
fCAB-seq with a linear correlation up to 50% 5fC abundance
(Figures S6C and S6D), which is sufficient to analyze almost all
potential 5fC sites as they are expected to exist in low
abundance.
We applied fCAB-seq to Tdgfl/fl and Tdg/ mESCs genomic
DNA, and subjected the bisulfite amplicons to high-throughput
sequencing in order to achieve sequencing depths sufficient to
distinguish low abundance hydroxylamine-protected 5fC from
the conventional bisulfite signals (1,0003 or higher coverage).
Using this approach, we were able to validate the presence and
accumulation of specific 5fC sites in genomic DNA within
five 5fC-marked endogenous loci (from fC-Seal) displaying
TDG-dependent accumulation of 5fC (Figures 6B, 6C, and
S6E–S6G, and Table S6, p < 0.005). We also confirmed that
hydroxylamine does not alter the behavior of cytosine in bisulfite
sequencing (Figure S6H).
We next employed a ChIP-fCAB-seq approach by capturing
H3K4me1-bound DNA via chromatin immunoprecipitation, in
which 5fC-marked regions defined by fC-Seal are enriched,
and then subjected the captured DNA to either conventional
bisulfite (Brinkman et al., 2012; Statham et al., 2012)
(H3K4me1-ChIP-Methyl-seq) or fCAB (H3K4me1-ChIP-fCAB-
seq) treatments, followed by sequencing (Figure 6D). We then
quantified the percentage of cytosine bases protected from
deamination in each treatment within active enhancers and
poised enhancers predicted to be linked to promoters (Shen
et al., 2012) because such enhancers display the most signifi-
cant enrichment of 5fC-marked regions (Figure S2E) in normal
mESCs. We found that within these poised enhancers, the
fCAB-seq treatment resulted in an increase in the fraction of
cytosines protected from deamination in the absence of TDG
(Tdg/ mESCs, 0.98% higher weighted average H3K4me1-
ChIP-fCAB signal, p = 5.255, Fisher’s exact), consistent with(C) Log2-fold-change in 5fC and 5hmC signals at the Tdg
/-specific p300-bin
mESCs) (D) and percent 5mC+5hmC (E) at p300 sites specific to Tdg/ (16,503) a
(F) The fraction of Tdg/-specific p300-binding sites (16,503) and 5fC-negative
and poised enhancers.
(G) Genome browser view of the Fgf4 locus at which multiple strong p300 sites la
enhancer (Shen et al., 2012) displaying a gain in 5fC and p300 in Tdg/ (yellow). S
mark. See also Figure S5.the occurrence and TDG-dependent regulation of 5fC at poised
enhancers (Figure 6E). At active enhancers H3K4me-ChIP-
Methyl-seq and H3K4me1-ChIP-fCAB-seq signals were very
similar (33.04% and 33.03%, respectively, p = 1.693) (Fig-
ure 6E). In Tdgfl/flmESCs, although we observed more variability
in H3K4me1-ChIP-Methyl-seq and H3K4me1-ChIP-fCAB-seq
signals, the increases in H3K4me1-ChIP-fCAB-seq relative to
H3K4me-ChIP-Methyl-seqwere reduced in comparison to those
in Tdg/ mESCs (Figures S6I and S6J).
DISCUSSION
Understanding TET-mediated 5mC oxidation has led to the iden-
tification of three additional DNA modifications in mammalian
genomes, 5hmC, 5fC, and 5caC. The study of 5hmC has
benefited greatly from the recent development of 5hmC-selec-
tive methods for affinity enrichment (Ficz et al., 2011; Pastor
et al., 2011; Song et al., 2011; Wu et al., 2011a) and base-reso-
lution detection (Booth et al., 2012; Yu et al., 2012). In particular,
base-resolution maps of 5hmC have demonstrated that the rela-
tive abundance is greatest at distal enhancers for mESCs
(Yu et al., 2012), suggesting a preference for active demethyla-
tion at such regulatory elements. There are also indications
that rather than serving only as an intermediate in an active
DNA demethylation pathway (Guo et al., 2011; He et al., 2011;
Ito et al., 2011), 5hmC may itself serve as a distinct and stable
epigenetic mark recognized by putative 5hmC-binding proteins
(Frauer et al., 2011; Melle´n et al., 2012; Spruijt et al., 2013;
Yildirim et al., 2011). However, the means by which 5hmC may
be dynamically regulated or stably maintained at distinct
genomic elements remains a central challenge. To meet this
challenge, it is essential to be able to accurately detect 5fC
and 5caC in genomic DNA. Here we present a pair of methods,
fC-Seal and fCAB-seq, which employ 5fC-selective chemical
manipulation to enable its affinity enrichment and base-resolu-
tion detection.
fC-Seal is developed as a highly selective chemical labeling
approach for the affinity purification and genome-wide profiling
of 5fC. By profiling 5hmC and 5fC in parallel using analogous
methods, we observed a relative decrease of 5mC that occurs
concomitant with an increased frequency and abundance of
5hmC at 5fC-marked regions when compared to 5hmC-marked
regions. We show that fhMRs occur more frequently than hMRs
at poised versus active enhancers, whereas other elements,
such as CTCF-binding sites, are more frequently marked with
5hmC in comparison to 5fC. Furthermore, when classifying
poised enhancers defined by chromatin state as associated
with fhMRs or hMRs, we found that the presence of 5fC corre-
lates with an increased abundance of 5hmC concomitant with
decreased 5mC levels as compared to hMRs. This observationding sites (16,503). (D-E) p300 ChIP-seq signals (reads/million/base, Tdg/
nd the 5fC-negative p300-binding sites common to Tdgfl/fl and Tdg/ (16,323).
p300-binding sites common to Tdgfl/fl and Tdg/(16,323) that occur at active
cking 5fC and 5hmC occur surrounding Fgf4 (gray), with a downstream poised
hown below each track are the regions defined as marked for each respective
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Figure 6. fCAB-Seq for Base-Resolution Detection of 5fC
(A) Schematic diagram of EtONH2-modified bisulfite sequencing for base-resolution detection of 5fC in genomic DNA (fCAB-seq).
(B) fCAB-seq validation of TDG-dependent 5fC in genomic DNA. An example of 5fC detection by fCAB-seq amplicon deep sequencing at a region of Epcam.
Sequencing depth = 14,208 ± 4,894.
(C) fCAB-seq validation of TDG-dependent 5fC in genomic DNA. An example of 5fC detection by fCAB-seq amplicon deep sequencing at a region of Ace.
Sequencing depth = 8,237 ± 2,133. For (B) and (C) 5fC track is equivalent to the signal fromEtONH2 treatment minus (5mC+hmC) signal. All 5fC bases shown have
p% 0.005, Fisher’s exact.
(legend continued on next page)
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supports a role for 5mC/5hmC oxidation to 5fC, and likely TDG-
dependent removal of 5fC, in dynamic DNA demethylation at
a subclass of poised enhancers. These results also indicate
that, in addition to chromatin modifications, DNA methylation
states can be informative in classification of gene regulatory
elements.
Comparison of 5hmC and 5fC profiles between wild-type and
Tdg KO mESCs further indicates distinct regulation of 5fC, but
not 5hmC, by TDG. However, we found that the effect of TDG
is greatest at regions of the genome that generally harbor inter-
mediate levels of DNA methylation (LMRs and poised
enhancers), as opposed to regions that can be classified as fully
methylated (FMRs) or unmethylated (UMRs, TSSs of highly
expressed genes, and active enhancers). These results indicate
distinct role(s) for 5fC and 5hmC in influencing the epigenetic
state and function of gene regulatory elements. To further
examine this possibility, we generated TDG-dependent binding
profiles of p300 as TDG and p300 are known to interact. We
found that the loss of TDG leads to a relatively large gain in the
overall number of p300-binding sites and that these sites also
accumulate 5fC. Intriguingly, the p300-binding sites acquired
in the absence TDG, which also accumulate 5fC, occur preferen-
tially at poised enhancers, whereas p300 sites common to Tdgfl/fl
and Tdg/mESCs, which are not marked by 5fC, occur prefer-
entially at active enhancers. These results indicate that 5fC
production coordinates with the binding of p300 at poised
enhancers, thus indicating functional roles for 5fC-based DNA
demethylation in the epigenetic priming of regulatory elements.
As a large fraction of sites marked by 5fC only in Tdg/mESCs
do not exhibit concomitant p300 binding (Figure S5D), and 5fC
is enriched at diverse gene regulatory elements, our data also
suggest that TDG-dependent regulation of 5fC could influence
other regulatory elements in a similar manner. Further assess-
ment of these regions in Tdgfl/fl and Tdg/ mESCs may yield
additional insight into the roles of 5mC/5hmCoxidation in embry-
onic stem cells.
We also developed a chemically assisted bisulfite sequencing
method, fCAB-seq, to detect the relative abundance of 5fC at
base resolution. We demonstrated that fCAB-seq is capable of
detecting low abundance 5fC at endogenous loci at levels
down to only a few percent when performed in combination
with high-throughput bisulfite amplicon sequencing. Finally, we
showed that the 5fC content at specific genomic elements could
be studied using aChIP-fCAB-seq approach to enrich subsets of
genomic elements harboring 5fC. By employing ChIP-fCAB-seq,
we confirmed the presence of 5fC at poised enhancers. The
approaches presented here are highly sensitive and selective
and have minimal background noise, which is critical in order
to accurately determine the distribution of 5fC given its low abun-
dance in the genome (Table S1).
In summary, we have developed and implemented two
methods for detecting and profiling 5-formylcytosine in genomic(D) Schematic diagram of ChIP-fCAB-seq. DNA fragments associated with H3K4m
of 5fC at base resolution.
(E) H3K4me1-ChIP-fCAB (Red) and H3K4m1-ChIP-Methyl-seq (Blue) signals at 5
active enhancers (right) in Tdg/ mESCs. Plotted are the weighted methylation
Table S6.DNA. Genome-wide maps of 5fC in mouse ESCs generated
using our approaches demonstrate the utility of mapping 5fC
beyond that afforded by mapping 5hmC alone in order to gain
additional insight into the general strategies employed by cells
for the regulated access of transcription factors to genetic infor-
mation. Use of fC-Seal in combination with detailed base-
resolution detection of 5fC by fCAB-seq represents a powerful
combination of tools for the future study of 5fC in any biological
context.
EXPERIMENTAL PROCEDURES
NaBH4-Based Selective Chemical Labeling and Capture of 5fC, fC-
Seal
A total of 50 mg sonicated mESC genomic DNA (average 400 bp) was incu-
bated in a 100 ml solution containing 50 mM HEPES buffer (pH 7.9), 25 mM
MgCl2, 300 mM unmodified UDP-Glc, and 2 mM bGT for 1 hr at 37
C. The
labeled DNA was purified by Micro Bio-Spin 6 spin columns (Bio-Rad,
exchange buffer to H2O first). NaBH4 solution was prepared by adding
1.5 mg of NaBH4 (Aldrich) in 1 ml of anhydrous methanol (Acros) and vortexing
until the entire solid dissolved. NaBH4 reduction was performed by adding
equal volume of freshly prepared NaBH4 solution to the DNA solution. The re-
action mixture was then vortexed and incubated for 15 min at room tempera-
ture. The DNA samples were purified by isopropanol precipitation and used for
azide-glucosylation, biotionylation and capture (see Extended Experimental
Procedures).
Hydroxylamine Protection of 5fC for Bisulfite Sequencing, fCAB-Seq
Hydroxylamine protection of 5fC was performed in 100 mM MES buffer (pH
5.0), 10 mM O-ethylhydroxylamine (Aldrich, 274992), and 100 ng/ml 76-mer
double-stranded synthetic DNA or sonicated genomic DNA (average
400 bp), or ChIP’d DNA for 2 hr at 37C. The DNA substrates were purified
by QIAGEN nucleotide removal kit and subjected to the sodium bisulfite treat-
ment by using EpiTect Bisulfite Kits (QIAGEN) following the manufacturers’
instructions except the bisulfite thermal cycle program was run twice or
high-throughput bisulfite amplicon sequencing was run (see Extended Exper-
imental Procedures).
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SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
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